nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—ABCG2—Rosuvastatin—atherosclerosis	0.0888	0.126	CbGbCtD
Rabeprazole—ABCG2—Ezetimibe—atherosclerosis	0.0888	0.126	CbGbCtD
Rabeprazole—ABCG2—Pravastatin—atherosclerosis	0.0808	0.115	CbGbCtD
Rabeprazole—CYP2C19—Rosuvastatin—atherosclerosis	0.0397	0.0563	CbGbCtD
Rabeprazole—CYP2C19—Simvastatin—atherosclerosis	0.0369	0.0524	CbGbCtD
Rabeprazole—CYP2C19—Lovastatin—atherosclerosis	0.0361	0.0513	CbGbCtD
Rabeprazole—CYP2D6—Niacin—atherosclerosis	0.0355	0.0504	CbGbCtD
Rabeprazole—CYP2C9—Rosuvastatin—atherosclerosis	0.033	0.0468	CbGbCtD
Rabeprazole—CYP2C9—Simvastatin—atherosclerosis	0.0307	0.0435	CbGbCtD
Rabeprazole—CYP2C9—Pravastatin—atherosclerosis	0.03	0.0426	CbGbCtD
Rabeprazole—CYP2C9—Lovastatin—atherosclerosis	0.03	0.0426	CbGbCtD
Rabeprazole—CYP2D6—Simvastatin—atherosclerosis	0.0281	0.0398	CbGbCtD
Rabeprazole—CYP2D6—Pravastatin—atherosclerosis	0.0275	0.039	CbGbCtD
Rabeprazole—CYP2D6—Lovastatin—atherosclerosis	0.0275	0.039	CbGbCtD
Rabeprazole—CYP3A4—Ezetimibe—atherosclerosis	0.0192	0.0272	CbGbCtD
Rabeprazole—CYP3A4—Rosuvastatin—atherosclerosis	0.0192	0.0272	CbGbCtD
Rabeprazole—CYP3A4—Simvastatin—atherosclerosis	0.0178	0.0253	CbGbCtD
Rabeprazole—CYP3A4—Pravastatin—atherosclerosis	0.0175	0.0248	CbGbCtD
Rabeprazole—CYP3A4—Lovastatin—atherosclerosis	0.0175	0.0248	CbGbCtD
Rabeprazole—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000358	0.00154	CcSEcCtD
Rabeprazole—Vision blurred—Lovastatin—atherosclerosis	0.000357	0.00154	CcSEcCtD
Rabeprazole—Tremor—Lovastatin—atherosclerosis	0.000355	0.00153	CcSEcCtD
Rabeprazole—Visual impairment—Pravastatin—atherosclerosis	0.000355	0.00153	CcSEcCtD
Rabeprazole—Erythema—Simvastatin—atherosclerosis	0.000355	0.00153	CcSEcCtD
Rabeprazole—Ill-defined disorder—Lovastatin—atherosclerosis	0.000352	0.00152	CcSEcCtD
Rabeprazole—Eye disorder—Niacin—atherosclerosis	0.00035	0.00151	CcSEcCtD
Rabeprazole—Flatulence—Simvastatin—atherosclerosis	0.00035	0.00151	CcSEcCtD
Rabeprazole—Tinnitus—Niacin—atherosclerosis	0.000349	0.0015	CcSEcCtD
Rabeprazole—Erythema multiforme—Pravastatin—atherosclerosis	0.000348	0.0015	CcSEcCtD
Rabeprazole—Dysgeusia—Simvastatin—atherosclerosis	0.000347	0.0015	CcSEcCtD
Rabeprazole—Angioedema—Lovastatin—atherosclerosis	0.000346	0.00149	CcSEcCtD
Rabeprazole—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000345	0.00149	CcSEcCtD
Rabeprazole—Anaemia—Ezetimibe—atherosclerosis	0.000344	0.00148	CcSEcCtD
Rabeprazole—Tinnitus—Pravastatin—atherosclerosis	0.000343	0.00148	CcSEcCtD
Rabeprazole—Malaise—Lovastatin—atherosclerosis	0.000342	0.00147	CcSEcCtD
Rabeprazole—Muscle spasms—Simvastatin—atherosclerosis	0.000341	0.00147	CcSEcCtD
Rabeprazole—Vertigo—Lovastatin—atherosclerosis	0.000341	0.00147	CcSEcCtD
Rabeprazole—Angioedema—Ezetimibe—atherosclerosis	0.00034	0.00146	CcSEcCtD
Rabeprazole—Angiopathy—Niacin—atherosclerosis	0.000339	0.00146	CcSEcCtD
Rabeprazole—Leukopenia—Lovastatin—atherosclerosis	0.000339	0.00146	CcSEcCtD
Rabeprazole—Chills—Niacin—atherosclerosis	0.000336	0.00145	CcSEcCtD
Rabeprazole—Malaise—Ezetimibe—atherosclerosis	0.000335	0.00144	CcSEcCtD
Rabeprazole—Vision blurred—Simvastatin—atherosclerosis	0.000334	0.00144	CcSEcCtD
Rabeprazole—Arrhythmia—Niacin—atherosclerosis	0.000334	0.00144	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000333	0.00143	CcSEcCtD
Rabeprazole—Tremor—Simvastatin—atherosclerosis	0.000332	0.00143	CcSEcCtD
Rabeprazole—Alopecia—Niacin—atherosclerosis	0.000331	0.00142	CcSEcCtD
Rabeprazole—Chills—Pravastatin—atherosclerosis	0.000331	0.00142	CcSEcCtD
Rabeprazole—Insomnia—Rosuvastatin—atherosclerosis	0.00033	0.00142	CcSEcCtD
Rabeprazole—Ill-defined disorder—Simvastatin—atherosclerosis	0.000329	0.00142	CcSEcCtD
Rabeprazole—Arrhythmia—Pravastatin—atherosclerosis	0.000329	0.00142	CcSEcCtD
Rabeprazole—Palpitations—Ezetimibe—atherosclerosis	0.000329	0.00142	CcSEcCtD
Rabeprazole—Paraesthesia—Rosuvastatin—atherosclerosis	0.000328	0.00141	CcSEcCtD
Rabeprazole—Anaemia—Simvastatin—atherosclerosis	0.000328	0.00141	CcSEcCtD
Rabeprazole—Malnutrition—Niacin—atherosclerosis	0.000326	0.0014	CcSEcCtD
Rabeprazole—Erythema—Niacin—atherosclerosis	0.000326	0.0014	CcSEcCtD
Rabeprazole—Alopecia—Pravastatin—atherosclerosis	0.000326	0.0014	CcSEcCtD
Rabeprazole—Cough—Ezetimibe—atherosclerosis	0.000325	0.0014	CcSEcCtD
Rabeprazole—Angioedema—Simvastatin—atherosclerosis	0.000324	0.0014	CcSEcCtD
Rabeprazole—Myalgia—Lovastatin—atherosclerosis	0.000323	0.00139	CcSEcCtD
Rabeprazole—Chest pain—Lovastatin—atherosclerosis	0.000323	0.00139	CcSEcCtD
Rabeprazole—Arthralgia—Lovastatin—atherosclerosis	0.000323	0.00139	CcSEcCtD
Rabeprazole—Anxiety—Lovastatin—atherosclerosis	0.000322	0.00139	CcSEcCtD
Rabeprazole—Dyspepsia—Rosuvastatin—atherosclerosis	0.000321	0.00138	CcSEcCtD
Rabeprazole—Hypertension—Ezetimibe—atherosclerosis	0.000321	0.00138	CcSEcCtD
Rabeprazole—Flatulence—Niacin—atherosclerosis	0.000321	0.00138	CcSEcCtD
Rabeprazole—Malaise—Simvastatin—atherosclerosis	0.00032	0.00138	CcSEcCtD
Rabeprazole—Tension—Niacin—atherosclerosis	0.00032	0.00138	CcSEcCtD
Rabeprazole—Discomfort—Lovastatin—atherosclerosis	0.000319	0.00137	CcSEcCtD
Rabeprazole—Vertigo—Simvastatin—atherosclerosis	0.000319	0.00137	CcSEcCtD
Rabeprazole—Leukopenia—Simvastatin—atherosclerosis	0.000317	0.00137	CcSEcCtD
Rabeprazole—Arthralgia—Ezetimibe—atherosclerosis	0.000317	0.00136	CcSEcCtD
Rabeprazole—Chest pain—Ezetimibe—atherosclerosis	0.000317	0.00136	CcSEcCtD
Rabeprazole—Myalgia—Ezetimibe—atherosclerosis	0.000317	0.00136	CcSEcCtD
Rabeprazole—Nervousness—Niacin—atherosclerosis	0.000316	0.00136	CcSEcCtD
Rabeprazole—Flatulence—Pravastatin—atherosclerosis	0.000316	0.00136	CcSEcCtD
Rabeprazole—Dry mouth—Lovastatin—atherosclerosis	0.000316	0.00136	CcSEcCtD
Rabeprazole—Tension—Pravastatin—atherosclerosis	0.000315	0.00136	CcSEcCtD
Rabeprazole—Dysgeusia—Pravastatin—atherosclerosis	0.000314	0.00135	CcSEcCtD
Rabeprazole—Muscle spasms—Niacin—atherosclerosis	0.000313	0.00135	CcSEcCtD
Rabeprazole—Discomfort—Ezetimibe—atherosclerosis	0.000313	0.00135	CcSEcCtD
Rabeprazole—Pain—Rosuvastatin—atherosclerosis	0.000312	0.00135	CcSEcCtD
Rabeprazole—Constipation—Rosuvastatin—atherosclerosis	0.000312	0.00135	CcSEcCtD
Rabeprazole—Confusional state—Lovastatin—atherosclerosis	0.000312	0.00134	CcSEcCtD
Rabeprazole—Nervousness—Pravastatin—atherosclerosis	0.000311	0.00134	CcSEcCtD
Rabeprazole—Dry mouth—Ezetimibe—atherosclerosis	0.00031	0.00133	CcSEcCtD
Rabeprazole—Anaphylactic shock—Lovastatin—atherosclerosis	0.000309	0.00133	CcSEcCtD
Rabeprazole—Muscle spasms—Pravastatin—atherosclerosis	0.000308	0.00133	CcSEcCtD
Rabeprazole—Vision blurred—Niacin—atherosclerosis	0.000307	0.00132	CcSEcCtD
Rabeprazole—Confusional state—Ezetimibe—atherosclerosis	0.000306	0.00132	CcSEcCtD
Rabeprazole—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000304	0.00131	CcSEcCtD
Rabeprazole—Thrombocytopenia—Lovastatin—atherosclerosis	0.000303	0.00131	CcSEcCtD
Rabeprazole—Vision blurred—Pravastatin—atherosclerosis	0.000302	0.0013	CcSEcCtD
Rabeprazole—Myalgia—Simvastatin—atherosclerosis	0.000302	0.0013	CcSEcCtD
Rabeprazole—Arthralgia—Simvastatin—atherosclerosis	0.000302	0.0013	CcSEcCtD
Rabeprazole—Chest pain—Simvastatin—atherosclerosis	0.000302	0.0013	CcSEcCtD
Rabeprazole—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000301	0.0013	CcSEcCtD
Rabeprazole—Anxiety—Simvastatin—atherosclerosis	0.000301	0.0013	CcSEcCtD
Rabeprazole—Tremor—Pravastatin—atherosclerosis	0.0003	0.00129	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000299	0.00129	CcSEcCtD
Rabeprazole—Discomfort—Simvastatin—atherosclerosis	0.000298	0.00129	CcSEcCtD
Rabeprazole—Angioedema—Niacin—atherosclerosis	0.000298	0.00128	CcSEcCtD
Rabeprazole—Ill-defined disorder—Pravastatin—atherosclerosis	0.000298	0.00128	CcSEcCtD
Rabeprazole—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000297	0.00128	CcSEcCtD
Rabeprazole—Anaemia—Pravastatin—atherosclerosis	0.000296	0.00128	CcSEcCtD
Rabeprazole—Anorexia—Lovastatin—atherosclerosis	0.000295	0.00127	CcSEcCtD
Rabeprazole—Angioedema—Pravastatin—atherosclerosis	0.000293	0.00126	CcSEcCtD
Rabeprazole—Vertigo—Niacin—atherosclerosis	0.000293	0.00126	CcSEcCtD
Rabeprazole—Syncope—Niacin—atherosclerosis	0.000292	0.00126	CcSEcCtD
Rabeprazole—Confusional state—Simvastatin—atherosclerosis	0.000292	0.00126	CcSEcCtD
Rabeprazole—Leukopenia—Niacin—atherosclerosis	0.000292	0.00126	CcSEcCtD
Rabeprazole—Urticaria—Rosuvastatin—atherosclerosis	0.00029	0.00125	CcSEcCtD
Rabeprazole—Oedema—Simvastatin—atherosclerosis	0.000289	0.00125	CcSEcCtD
Rabeprazole—Anaphylactic shock—Simvastatin—atherosclerosis	0.000289	0.00125	CcSEcCtD
Rabeprazole—Malaise—Pravastatin—atherosclerosis	0.000289	0.00125	CcSEcCtD
Rabeprazole—Abdominal pain—Rosuvastatin—atherosclerosis	0.000289	0.00124	CcSEcCtD
Rabeprazole—Vertigo—Pravastatin—atherosclerosis	0.000288	0.00124	CcSEcCtD
Rabeprazole—Palpitations—Niacin—atherosclerosis	0.000288	0.00124	CcSEcCtD
Rabeprazole—Leukopenia—Pravastatin—atherosclerosis	0.000287	0.00124	CcSEcCtD
Rabeprazole—Loss of consciousness—Niacin—atherosclerosis	0.000286	0.00123	CcSEcCtD
Rabeprazole—Cough—Niacin—atherosclerosis	0.000284	0.00122	CcSEcCtD
Rabeprazole—Thrombocytopenia—Simvastatin—atherosclerosis	0.000283	0.00122	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000282	0.00121	CcSEcCtD
Rabeprazole—Insomnia—Lovastatin—atherosclerosis	0.00028	0.00121	CcSEcCtD
Rabeprazole—Cough—Pravastatin—atherosclerosis	0.00028	0.00121	CcSEcCtD
Rabeprazole—Paraesthesia—Lovastatin—atherosclerosis	0.000278	0.0012	CcSEcCtD
Rabeprazole—Myalgia—Niacin—atherosclerosis	0.000277	0.00119	CcSEcCtD
Rabeprazole—Arthralgia—Niacin—atherosclerosis	0.000277	0.00119	CcSEcCtD
Rabeprazole—Hypertension—Pravastatin—atherosclerosis	0.000277	0.00119	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000277	0.00119	CcSEcCtD
Rabeprazole—Anorexia—Simvastatin—atherosclerosis	0.000276	0.00119	CcSEcCtD
Rabeprazole—Dyspnoea—Lovastatin—atherosclerosis	0.000276	0.00119	CcSEcCtD
Rabeprazole—Insomnia—Ezetimibe—atherosclerosis	0.000275	0.00118	CcSEcCtD
Rabeprazole—Arthralgia—Pravastatin—atherosclerosis	0.000273	0.00118	CcSEcCtD
Rabeprazole—Chest pain—Pravastatin—atherosclerosis	0.000273	0.00118	CcSEcCtD
Rabeprazole—Myalgia—Pravastatin—atherosclerosis	0.000273	0.00118	CcSEcCtD
Rabeprazole—Paraesthesia—Ezetimibe—atherosclerosis	0.000273	0.00117	CcSEcCtD
Rabeprazole—Dyspepsia—Lovastatin—atherosclerosis	0.000272	0.00117	CcSEcCtD
Rabeprazole—Anxiety—Pravastatin—atherosclerosis	0.000272	0.00117	CcSEcCtD
Rabeprazole—Dry mouth—Niacin—atherosclerosis	0.000271	0.00117	CcSEcCtD
Rabeprazole—Dyspnoea—Ezetimibe—atherosclerosis	0.000271	0.00117	CcSEcCtD
Rabeprazole—Discomfort—Pravastatin—atherosclerosis	0.00027	0.00116	CcSEcCtD
Rabeprazole—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000269	0.00116	CcSEcCtD
Rabeprazole—Decreased appetite—Lovastatin—atherosclerosis	0.000269	0.00116	CcSEcCtD
Rabeprazole—Dyspepsia—Ezetimibe—atherosclerosis	0.000267	0.00115	CcSEcCtD
Rabeprazole—Anaphylactic shock—Niacin—atherosclerosis	0.000266	0.00114	CcSEcCtD
Rabeprazole—Oedema—Niacin—atherosclerosis	0.000266	0.00114	CcSEcCtD
Rabeprazole—Pain—Lovastatin—atherosclerosis	0.000265	0.00114	CcSEcCtD
Rabeprazole—Constipation—Lovastatin—atherosclerosis	0.000265	0.00114	CcSEcCtD
Rabeprazole—Confusional state—Pravastatin—atherosclerosis	0.000264	0.00114	CcSEcCtD
Rabeprazole—Decreased appetite—Ezetimibe—atherosclerosis	0.000264	0.00114	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000264	0.00114	CcSEcCtD
Rabeprazole—Asthenia—Rosuvastatin—atherosclerosis	0.000262	0.00113	CcSEcCtD
Rabeprazole—Insomnia—Simvastatin—atherosclerosis	0.000262	0.00113	CcSEcCtD
Rabeprazole—Anaphylactic shock—Pravastatin—atherosclerosis	0.000262	0.00113	CcSEcCtD
Rabeprazole—Oedema—Pravastatin—atherosclerosis	0.000262	0.00113	CcSEcCtD
Rabeprazole—Shock—Niacin—atherosclerosis	0.000262	0.00113	CcSEcCtD
Rabeprazole—Paraesthesia—Simvastatin—atherosclerosis	0.00026	0.00112	CcSEcCtD
Rabeprazole—Constipation—Ezetimibe—atherosclerosis	0.00026	0.00112	CcSEcCtD
Rabeprazole—Pain—Ezetimibe—atherosclerosis	0.00026	0.00112	CcSEcCtD
Rabeprazole—Tachycardia—Niacin—atherosclerosis	0.000259	0.00112	CcSEcCtD
Rabeprazole—Pruritus—Rosuvastatin—atherosclerosis	0.000258	0.00111	CcSEcCtD
Rabeprazole—Dyspnoea—Simvastatin—atherosclerosis	0.000258	0.00111	CcSEcCtD
Rabeprazole—Hyperhidrosis—Niacin—atherosclerosis	0.000257	0.00111	CcSEcCtD
Rabeprazole—Thrombocytopenia—Pravastatin—atherosclerosis	0.000256	0.0011	CcSEcCtD
Rabeprazole—Feeling abnormal—Lovastatin—atherosclerosis	0.000255	0.0011	CcSEcCtD
Rabeprazole—Dyspepsia—Simvastatin—atherosclerosis	0.000255	0.0011	CcSEcCtD
Rabeprazole—Anorexia—Niacin—atherosclerosis	0.000253	0.00109	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000253	0.00109	CcSEcCtD
Rabeprazole—Hyperhidrosis—Pravastatin—atherosclerosis	0.000253	0.00109	CcSEcCtD
Rabeprazole—Decreased appetite—Simvastatin—atherosclerosis	0.000252	0.00108	CcSEcCtD
Rabeprazole—Feeling abnormal—Ezetimibe—atherosclerosis	0.00025	0.00108	CcSEcCtD
Rabeprazole—Diarrhoea—Rosuvastatin—atherosclerosis	0.00025	0.00108	CcSEcCtD
Rabeprazole—Anorexia—Pravastatin—atherosclerosis	0.000249	0.00107	CcSEcCtD
Rabeprazole—Hypotension—Niacin—atherosclerosis	0.000248	0.00107	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000248	0.00107	CcSEcCtD
Rabeprazole—Pain—Simvastatin—atherosclerosis	0.000248	0.00107	CcSEcCtD
Rabeprazole—Constipation—Simvastatin—atherosclerosis	0.000248	0.00107	CcSEcCtD
Rabeprazole—Urticaria—Lovastatin—atherosclerosis	0.000246	0.00106	CcSEcCtD
Rabeprazole—Abdominal pain—Lovastatin—atherosclerosis	0.000245	0.00105	CcSEcCtD
Rabeprazole—Body temperature increased—Lovastatin—atherosclerosis	0.000245	0.00105	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000242	0.00104	CcSEcCtD
Rabeprazole—Dizziness—Rosuvastatin—atherosclerosis	0.000241	0.00104	CcSEcCtD
Rabeprazole—Urticaria—Ezetimibe—atherosclerosis	0.000241	0.00104	CcSEcCtD
Rabeprazole—Insomnia—Niacin—atherosclerosis	0.00024	0.00104	CcSEcCtD
Rabeprazole—Abdominal pain—Ezetimibe—atherosclerosis	0.00024	0.00103	CcSEcCtD
Rabeprazole—Body temperature increased—Ezetimibe—atherosclerosis	0.00024	0.00103	CcSEcCtD
Rabeprazole—Paraesthesia—Niacin—atherosclerosis	0.000239	0.00103	CcSEcCtD
Rabeprazole—Feeling abnormal—Simvastatin—atherosclerosis	0.000239	0.00103	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000238	0.00103	CcSEcCtD
Rabeprazole—Dyspnoea—Niacin—atherosclerosis	0.000237	0.00102	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000237	0.00102	CcSEcCtD
Rabeprazole—Insomnia—Pravastatin—atherosclerosis	0.000237	0.00102	CcSEcCtD
Rabeprazole—Somnolence—Niacin—atherosclerosis	0.000236	0.00102	CcSEcCtD
Rabeprazole—Paraesthesia—Pravastatin—atherosclerosis	0.000235	0.00101	CcSEcCtD
Rabeprazole—Dyspepsia—Niacin—atherosclerosis	0.000234	0.00101	CcSEcCtD
Rabeprazole—Dyspnoea—Pravastatin—atherosclerosis	0.000233	0.00101	CcSEcCtD
Rabeprazole—Decreased appetite—Niacin—atherosclerosis	0.000231	0.000995	CcSEcCtD
Rabeprazole—Dyspepsia—Pravastatin—atherosclerosis	0.00023	0.000992	CcSEcCtD
Rabeprazole—Rash—Rosuvastatin—atherosclerosis	0.00023	0.000992	CcSEcCtD
Rabeprazole—Dermatitis—Rosuvastatin—atherosclerosis	0.00023	0.000991	CcSEcCtD
Rabeprazole—Urticaria—Simvastatin—atherosclerosis	0.00023	0.000991	CcSEcCtD
Rabeprazole—Abdominal pain—Simvastatin—atherosclerosis	0.000229	0.000986	CcSEcCtD
Rabeprazole—Body temperature increased—Simvastatin—atherosclerosis	0.000229	0.000986	CcSEcCtD
Rabeprazole—Headache—Rosuvastatin—atherosclerosis	0.000229	0.000985	CcSEcCtD
Rabeprazole—Hypersensitivity—Lovastatin—atherosclerosis	0.000228	0.000982	CcSEcCtD
Rabeprazole—Decreased appetite—Pravastatin—atherosclerosis	0.000228	0.00098	CcSEcCtD
Rabeprazole—Pain—Niacin—atherosclerosis	0.000227	0.000979	CcSEcCtD
Rabeprazole—Constipation—Pravastatin—atherosclerosis	0.000224	0.000964	CcSEcCtD
Rabeprazole—Pain—Pravastatin—atherosclerosis	0.000224	0.000964	CcSEcCtD
Rabeprazole—Hypersensitivity—Ezetimibe—atherosclerosis	0.000224	0.000963	CcSEcCtD
Rabeprazole—Asthenia—Lovastatin—atherosclerosis	0.000222	0.000956	CcSEcCtD
Rabeprazole—Pruritus—Lovastatin—atherosclerosis	0.000219	0.000943	CcSEcCtD
Rabeprazole—Asthenia—Ezetimibe—atherosclerosis	0.000218	0.000938	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Niacin—atherosclerosis	0.000217	0.000936	CcSEcCtD
Rabeprazole—Nausea—Rosuvastatin—atherosclerosis	0.000217	0.000934	CcSEcCtD
Rabeprazole—Feeling abnormal—Pravastatin—atherosclerosis	0.000216	0.000929	CcSEcCtD
Rabeprazole—Pruritus—Ezetimibe—atherosclerosis	0.000215	0.000925	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000214	0.000922	CcSEcCtD
Rabeprazole—Hypersensitivity—Simvastatin—atherosclerosis	0.000213	0.000919	CcSEcCtD
Rabeprazole—Diarrhoea—Lovastatin—atherosclerosis	0.000212	0.000912	CcSEcCtD
Rabeprazole—Urticaria—Niacin—atherosclerosis	0.000211	0.00091	CcSEcCtD
Rabeprazole—Abdominal pain—Niacin—atherosclerosis	0.00021	0.000905	CcSEcCtD
Rabeprazole—Body temperature increased—Niacin—atherosclerosis	0.00021	0.000905	CcSEcCtD
Rabeprazole—Urticaria—Pravastatin—atherosclerosis	0.000208	0.000896	CcSEcCtD
Rabeprazole—Asthenia—Simvastatin—atherosclerosis	0.000208	0.000895	CcSEcCtD
Rabeprazole—Diarrhoea—Ezetimibe—atherosclerosis	0.000208	0.000895	CcSEcCtD
Rabeprazole—Body temperature increased—Pravastatin—atherosclerosis	0.000207	0.000891	CcSEcCtD
Rabeprazole—Abdominal pain—Pravastatin—atherosclerosis	0.000207	0.000891	CcSEcCtD
Rabeprazole—Pruritus—Simvastatin—atherosclerosis	0.000205	0.000882	CcSEcCtD
Rabeprazole—Dizziness—Lovastatin—atherosclerosis	0.000205	0.000882	CcSEcCtD
Rabeprazole—Dizziness—Ezetimibe—atherosclerosis	0.000201	0.000865	CcSEcCtD
Rabeprazole—Diarrhoea—Simvastatin—atherosclerosis	0.000198	0.000853	CcSEcCtD
Rabeprazole—Vomiting—Lovastatin—atherosclerosis	0.000197	0.000848	CcSEcCtD
Rabeprazole—Hypersensitivity—Niacin—atherosclerosis	0.000196	0.000844	CcSEcCtD
Rabeprazole—Rash—Lovastatin—atherosclerosis	0.000195	0.000841	CcSEcCtD
Rabeprazole—Dermatitis—Lovastatin—atherosclerosis	0.000195	0.00084	CcSEcCtD
Rabeprazole—Headache—Lovastatin—atherosclerosis	0.000194	0.000835	CcSEcCtD
Rabeprazole—Vomiting—Ezetimibe—atherosclerosis	0.000193	0.000831	CcSEcCtD
Rabeprazole—Hypersensitivity—Pravastatin—atherosclerosis	0.000193	0.000831	CcSEcCtD
Rabeprazole—Dizziness—Simvastatin—atherosclerosis	0.000191	0.000825	CcSEcCtD
Rabeprazole—Rash—Ezetimibe—atherosclerosis	0.000191	0.000824	CcSEcCtD
Rabeprazole—Dermatitis—Ezetimibe—atherosclerosis	0.000191	0.000824	CcSEcCtD
Rabeprazole—Asthenia—Niacin—atherosclerosis	0.000191	0.000821	CcSEcCtD
Rabeprazole—Headache—Ezetimibe—atherosclerosis	0.00019	0.000819	CcSEcCtD
Rabeprazole—Pruritus—Niacin—atherosclerosis	0.000188	0.00081	CcSEcCtD
Rabeprazole—Asthenia—Pravastatin—atherosclerosis	0.000188	0.000809	CcSEcCtD
Rabeprazole—Pruritus—Pravastatin—atherosclerosis	0.000185	0.000798	CcSEcCtD
Rabeprazole—Vomiting—Simvastatin—atherosclerosis	0.000184	0.000793	CcSEcCtD
Rabeprazole—Nausea—Lovastatin—atherosclerosis	0.000184	0.000792	CcSEcCtD
Rabeprazole—Rash—Simvastatin—atherosclerosis	0.000183	0.000786	CcSEcCtD
Rabeprazole—Dermatitis—Simvastatin—atherosclerosis	0.000182	0.000785	CcSEcCtD
Rabeprazole—Diarrhoea—Niacin—atherosclerosis	0.000182	0.000783	CcSEcCtD
Rabeprazole—Headache—Simvastatin—atherosclerosis	0.000181	0.000781	CcSEcCtD
Rabeprazole—Nausea—Ezetimibe—atherosclerosis	0.00018	0.000777	CcSEcCtD
Rabeprazole—Diarrhoea—Pravastatin—atherosclerosis	0.000179	0.000771	CcSEcCtD
Rabeprazole—Dizziness—Niacin—atherosclerosis	0.000176	0.000757	CcSEcCtD
Rabeprazole—Dizziness—Pravastatin—atherosclerosis	0.000173	0.000745	CcSEcCtD
Rabeprazole—Nausea—Simvastatin—atherosclerosis	0.000172	0.000741	CcSEcCtD
Rabeprazole—Vomiting—Niacin—atherosclerosis	0.000169	0.000728	CcSEcCtD
Rabeprazole—Rash—Niacin—atherosclerosis	0.000168	0.000722	CcSEcCtD
Rabeprazole—Dermatitis—Niacin—atherosclerosis	0.000167	0.000721	CcSEcCtD
Rabeprazole—Headache—Niacin—atherosclerosis	0.000167	0.000717	CcSEcCtD
Rabeprazole—Vomiting—Pravastatin—atherosclerosis	0.000166	0.000717	CcSEcCtD
Rabeprazole—Rash—Pravastatin—atherosclerosis	0.000165	0.000711	CcSEcCtD
Rabeprazole—Dermatitis—Pravastatin—atherosclerosis	0.000165	0.00071	CcSEcCtD
Rabeprazole—Headache—Pravastatin—atherosclerosis	0.000164	0.000706	CcSEcCtD
Rabeprazole—Nausea—Niacin—atherosclerosis	0.000158	0.00068	CcSEcCtD
Rabeprazole—Nausea—Pravastatin—atherosclerosis	0.000155	0.00067	CcSEcCtD
Rabeprazole—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.55e-05	0.000245	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.55e-05	0.000244	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CETP—atherosclerosis	1.54e-05	0.000243	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP7A1—atherosclerosis	1.53e-05	0.000241	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.53e-05	0.000241	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	1.52e-05	0.000239	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—LPA—atherosclerosis	1.51e-05	0.000238	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—APOB—atherosclerosis	1.51e-05	0.000237	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.5e-05	0.000236	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—LPA—atherosclerosis	1.5e-05	0.000236	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.49e-05	0.000234	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.48e-05	0.000234	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—SCARB1—atherosclerosis	1.47e-05	0.000232	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GSTM1—atherosclerosis	1.46e-05	0.000231	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.46e-05	0.000231	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—BGN—atherosclerosis	1.46e-05	0.000231	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.46e-05	0.00023	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—BGN—atherosclerosis	1.45e-05	0.000229	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—APOA5—atherosclerosis	1.45e-05	0.000228	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.44e-05	0.000227	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—LPL—atherosclerosis	1.44e-05	0.000227	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—APOA5—atherosclerosis	1.44e-05	0.000226	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.43e-05	0.000226	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.42e-05	0.000223	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GPX1—atherosclerosis	1.4e-05	0.000221	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.39e-05	0.00022	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.39e-05	0.00022	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.39e-05	0.00022	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—HMGCR—atherosclerosis	1.39e-05	0.000219	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.38e-05	0.000218	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.37e-05	0.000216	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CD36—atherosclerosis	1.37e-05	0.000215	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.36e-05	0.000214	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.35e-05	0.000214	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.35e-05	0.000213	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.35e-05	0.000213	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.35e-05	0.000212	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.34e-05	0.000212	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—APOA2—atherosclerosis	1.34e-05	0.000212	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.34e-05	0.000212	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.34e-05	0.000212	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.34e-05	0.000211	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.33e-05	0.000209	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.32e-05	0.000209	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.31e-05	0.000207	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.31e-05	0.000206	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—LIPC—atherosclerosis	1.31e-05	0.000206	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.3e-05	0.000206	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—APOC3—atherosclerosis	1.3e-05	0.000205	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—MTHFR—atherosclerosis	1.29e-05	0.000204	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—LDLR—atherosclerosis	1.29e-05	0.000203	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—LPA—atherosclerosis	1.28e-05	0.000202	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PPARA—atherosclerosis	1.27e-05	0.0002	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CETP—atherosclerosis	1.26e-05	0.000199	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.26e-05	0.000198	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ABCA1—atherosclerosis	1.24e-05	0.000196	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—BGN—atherosclerosis	1.24e-05	0.000196	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.23e-05	0.000195	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.23e-05	0.000194	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AGT—atherosclerosis	1.23e-05	0.000194	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—APOA5—atherosclerosis	1.23e-05	0.000194	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—FABP4—atherosclerosis	1.23e-05	0.000193	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—LCAT—atherosclerosis	1.23e-05	0.000193	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.21e-05	0.00019	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.21e-05	0.00019	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—APOE—atherosclerosis	1.21e-05	0.00019	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—APOA4—atherosclerosis	1.2e-05	0.00019	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—LIPC—atherosclerosis	1.2e-05	0.000189	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.2e-05	0.000189	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CAV1—atherosclerosis	1.19e-05	0.000188	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—APOC3—atherosclerosis	1.19e-05	0.000188	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.19e-05	0.000188	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—APOA1—atherosclerosis	1.19e-05	0.000188	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.19e-05	0.000188	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—LIPC—atherosclerosis	1.19e-05	0.000188	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—LDLR—atherosclerosis	1.19e-05	0.000187	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—APOC3—atherosclerosis	1.18e-05	0.000187	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.18e-05	0.000186	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.18e-05	0.000186	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—LDLR—atherosclerosis	1.18e-05	0.000185	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.17e-05	0.000185	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.17e-05	0.000184	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CETP—atherosclerosis	1.16e-05	0.000183	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.16e-05	0.000182	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.15e-05	0.000182	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CETP—atherosclerosis	1.15e-05	0.000181	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.14e-05	0.00018	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.14e-05	0.00018	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.11e-05	0.000175	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.1e-05	0.000173	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.09e-05	0.000172	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CG—atherosclerosis	1.09e-05	0.000172	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.07e-05	0.000169	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—HMOX1—atherosclerosis	1.06e-05	0.000168	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.05e-05	0.000166	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PPARG—atherosclerosis	1.05e-05	0.000166	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.05e-05	0.000165	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.04e-05	0.000164	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.04e-05	0.000163	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—APOA2—atherosclerosis	1.04e-05	0.000163	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.04e-05	0.000163	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.04e-05	0.000163	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—INS—atherosclerosis	1.03e-05	0.000162	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.03e-05	0.000162	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.02e-05	0.000161	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.02e-05	0.000161	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—APOB—atherosclerosis	1.02e-05	0.000161	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.02e-05	0.00016	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—LIPC—atherosclerosis	1.02e-05	0.00016	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.01e-05	0.00016	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—APOC3—atherosclerosis	1.01e-05	0.000159	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—LDLR—atherosclerosis	1e-05	0.000158	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTM1—atherosclerosis	9.91e-06	0.000156	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—LPA—atherosclerosis	9.88e-06	0.000156	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CETP—atherosclerosis	9.81e-06	0.000155	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—LPL—atherosclerosis	9.73e-06	0.000153	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—BGN—atherosclerosis	9.57e-06	0.000151	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GPX1—atherosclerosis	9.49e-06	0.00015	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—APOA5—atherosclerosis	9.47e-06	0.000149	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ALB—atherosclerosis	9.44e-06	0.000149	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SCARB1—atherosclerosis	9.4e-06	0.000148	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.37e-06	0.000148	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ABCA1—atherosclerosis	9.33e-06	0.000147	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ABCA1—atherosclerosis	9.25e-06	0.000146	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CD36—atherosclerosis	9.25e-06	0.000146	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.15e-06	0.000144	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	9.12e-06	0.000144	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—NOS3—atherosclerosis	9.03e-06	0.000142	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HMGCR—atherosclerosis	8.87e-06	0.00014	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALOX5—atherosclerosis	8.8e-06	0.000139	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—MTHFR—atherosclerosis	8.76e-06	0.000138	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—HMOX1—atherosclerosis	8.71e-06	0.000137	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PPARA—atherosclerosis	8.6e-06	0.000136	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—APOB—atherosclerosis	8.34e-06	0.000132	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AGT—atherosclerosis	8.33e-06	0.000131	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTGS2—atherosclerosis	8.26e-06	0.00013	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—APOE—atherosclerosis	8.16e-06	0.000129	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTM1—atherosclerosis	8.11e-06	0.000128	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CAV1—atherosclerosis	8.08e-06	0.000127	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—APOA1—atherosclerosis	8.06e-06	0.000127	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—HMOX1—atherosclerosis	8.01e-06	0.000126	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8e-06	0.000126	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—LPL—atherosclerosis	7.96e-06	0.000126	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—HMOX1—atherosclerosis	7.94e-06	0.000125	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ABCA1—atherosclerosis	7.91e-06	0.000125	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.9e-06	0.000125	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—LIPC—atherosclerosis	7.85e-06	0.000124	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—APOC3—atherosclerosis	7.8e-06	0.000123	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GPX1—atherosclerosis	7.77e-06	0.000123	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—LDLR—atherosclerosis	7.75e-06	0.000122	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—APOB—atherosclerosis	7.67e-06	0.000121	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—APOB—atherosclerosis	7.61e-06	0.00012	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CETP—atherosclerosis	7.57e-06	0.000119	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CD36—atherosclerosis	7.57e-06	0.000119	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTM1—atherosclerosis	7.46e-06	0.000118	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTM1—atherosclerosis	7.4e-06	0.000117	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CG—atherosclerosis	7.36e-06	0.000116	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—LPL—atherosclerosis	7.32e-06	0.000116	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—LPL—atherosclerosis	7.26e-06	0.000115	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SCARB1—atherosclerosis	7.25e-06	0.000114	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—MTHFR—atherosclerosis	7.17e-06	0.000113	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GPX1—atherosclerosis	7.15e-06	0.000113	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PPARG—atherosclerosis	7.11e-06	0.000112	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GPX1—atherosclerosis	7.08e-06	0.000112	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PPARA—atherosclerosis	7.03e-06	0.000111	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—INS—atherosclerosis	6.97e-06	0.00011	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CD36—atherosclerosis	6.96e-06	0.00011	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CD36—atherosclerosis	6.9e-06	0.000109	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.85e-06	0.000108	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AGT—atherosclerosis	6.81e-06	0.000107	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HMOX1—atherosclerosis	6.78e-06	0.000107	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—APOE—atherosclerosis	6.68e-06	0.000105	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CAV1—atherosclerosis	6.61e-06	0.000104	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—APOA1—atherosclerosis	6.6e-06	0.000104	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—MTHFR—atherosclerosis	6.6e-06	0.000104	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—MTHFR—atherosclerosis	6.54e-06	0.000103	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—APOB—atherosclerosis	6.5e-06	0.000102	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PPARA—atherosclerosis	6.47e-06	0.000102	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PPARA—atherosclerosis	6.41e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ALB—atherosclerosis	6.39e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTM1—atherosclerosis	6.32e-06	9.97e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AGT—atherosclerosis	6.27e-06	9.88e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AGT—atherosclerosis	6.21e-06	9.8e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—LPL—atherosclerosis	6.21e-06	9.79e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—APOE—atherosclerosis	6.14e-06	9.68e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—NOS3—atherosclerosis	6.11e-06	9.64e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.1e-06	9.62e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—APOE—atherosclerosis	6.09e-06	9.6e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CAV1—atherosclerosis	6.08e-06	9.59e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—APOA1—atherosclerosis	6.07e-06	9.57e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GPX1—atherosclerosis	6.05e-06	9.55e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CAV1—atherosclerosis	6.03e-06	9.51e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CG—atherosclerosis	6.02e-06	9.5e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—APOA1—atherosclerosis	6.02e-06	9.49e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CD36—atherosclerosis	5.9e-06	9.3e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PPARG—atherosclerosis	5.81e-06	9.17e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—INS—atherosclerosis	5.7e-06	8.99e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTGS2—atherosclerosis	5.59e-06	8.82e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—MTHFR—atherosclerosis	5.59e-06	8.81e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CG—atherosclerosis	5.54e-06	8.74e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CG—atherosclerosis	5.49e-06	8.66e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PPARA—atherosclerosis	5.48e-06	8.64e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PPARG—atherosclerosis	5.35e-06	8.43e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AGT—atherosclerosis	5.31e-06	8.37e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PPARG—atherosclerosis	5.3e-06	8.36e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—INS—atherosclerosis	5.25e-06	8.27e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.24e-06	8.26e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALB—atherosclerosis	5.23e-06	8.25e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—APOE—atherosclerosis	5.2e-06	8.2e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—INS—atherosclerosis	5.2e-06	8.2e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CAV1—atherosclerosis	5.15e-06	8.13e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—APOA1—atherosclerosis	5.14e-06	8.11e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—APOB—atherosclerosis	5.02e-06	7.91e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NOS3—atherosclerosis	5e-06	7.89e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.88e-06	7.69e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALB—atherosclerosis	4.81e-06	7.58e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—LPL—atherosclerosis	4.79e-06	7.55e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALB—atherosclerosis	4.77e-06	7.52e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CG—atherosclerosis	4.69e-06	7.4e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GPX1—atherosclerosis	4.67e-06	7.37e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NOS3—atherosclerosis	4.6e-06	7.25e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTGS2—atherosclerosis	4.57e-06	7.21e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NOS3—atherosclerosis	4.56e-06	7.19e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CD36—atherosclerosis	4.55e-06	7.18e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PPARG—atherosclerosis	4.53e-06	7.14e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—INS—atherosclerosis	4.44e-06	7.01e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.31e-06	6.8e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PPARA—atherosclerosis	4.23e-06	6.67e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTGS2—atherosclerosis	4.21e-06	6.63e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTGS2—atherosclerosis	4.17e-06	6.58e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AKT1—atherosclerosis	4.15e-06	6.55e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AGT—atherosclerosis	4.1e-06	6.46e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALB—atherosclerosis	4.07e-06	6.42e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—APOE—atherosclerosis	4.01e-06	6.33e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CAV1—atherosclerosis	3.98e-06	6.27e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—APOA1—atherosclerosis	3.97e-06	6.26e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NOS3—atherosclerosis	3.9e-06	6.15e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.62e-06	5.71e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.56e-06	5.62e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PPARG—atherosclerosis	3.5e-06	5.51e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—INS—atherosclerosis	3.43e-06	5.41e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALB—atherosclerosis	3.14e-06	4.96e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NOS3—atherosclerosis	3.01e-06	4.74e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AKT1—atherosclerosis	2.81e-06	4.43e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.75e-06	4.34e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AKT1—atherosclerosis	2.3e-06	3.63e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AKT1—atherosclerosis	2.11e-06	3.33e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AKT1—atherosclerosis	2.1e-06	3.31e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AKT1—atherosclerosis	1.79e-06	2.82e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AKT1—atherosclerosis	1.38e-06	2.18e-05	CbGpPWpGaD
